MedTrace Logo

Early Markers of Radiation-Induced Cardiac Injury in Hodgkin Lymphoma Treated With Radiation Therapy

NCT02404818 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2022-06-10

No results posted yet for this study

Summary

The purpose of this study is to evaluate if radiation and chemotherapy treatment cause cardiac abnormalities among survivors of Hodgkin's lymphoma.

Conditions

  • Hodgkin's Lymphoma

Interventions

PROCEDURE

Cardiac Magnetic Resonance Imaging

A cardiac MRI will be performed.

PROCEDURE

Echocardiogram

An echocardiogram will be performed for the following information: M-mode, two-dimensional, Doppler blood flow measurements, and longitudinal strain and strain rate imaging

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • Bradford S Hoppe, MD, MPH · University of Florida Health Proton Therapy Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2021-04-14
Completion
2021-04-14

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02404818 on ClinicalTrials.gov